Legal & General Group PLC Avrobio, Inc. Transaction History

Legal & General Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.75 - $1.33 $2,271 - $4,028	-3,029 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $31,150 - $54,625	-9,029 Reduced 74.88%	3,029 $12,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $38,665 - $64,885	6,992 Added 138.02%	12,058 $67,000
Q2 2021 Aug 12, 2021	SELL	$7.84 - $12.6 $10,544 - $16,947	-1,345 Reduced 20.98%	5,066 $45,000
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $21,543 - $39,449	2,044 Added 46.81%	6,411 $81,000
Q3 2020 Nov 13, 2020	SELL	$12.99 - $19.41 $16,536 - $24,708	-1,273 Reduced 22.57%	4,367 $57,000
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $15,432 - $29,067	1,266 Added 28.94%	5,640 $99,000
Q1 2020 May 14, 2020	SELL	$10.08 - $27.21 $4,667 - $12,598	-463 Reduced 9.57%	4,374 $69,000
Q4 2019 Feb 13, 2020	BUY	$13.05 - $21.88 $11,157 - $18,707	855 Added 21.47%	4,837 $97,000
Q3 2019 Nov 13, 2019	BUY	$14.12 - $23.44 $11,084 - $18,400	785 Added 24.55%	3,982 $56,000
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $14,081 - $29,091	1,066 Added 50.02%	3,197 $49,000
Q1 2019 May 15, 2019	BUY	$12.46 - $22.05 $15,113 - $26,746	1,213 Added 132.14%	2,131 $47,000
Q3 2018 Nov 20, 2018	BUY	$26.95 - $52.7 $24,740 - $48,378	918 New	918 $48,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.